Newsroom

latest news from ose
and across our portfolio

Featured News

Oxford Science Enterprises Appoints Ed Bussey as Chief Executive Officer
Oxford Science Enterprises Appoints Ed Bussey as Chief Executive OfficerArticle links to www.beacontx.com
Beacon Therapeutics
Beacon Therapeutics launches with £96 million to develop a new generation of gene therapies for retinal diseasesArticle links to www.caristo.com
Caristo Diagnostics
Caristo Diagnostics Completes Series A Financing and Welcomes New CEOArticle links to quantummotion.tech
Quantum Motion Technologies
Quantum Motion Raises £42 Million Investment RoundArticle links to spybiotech.com
SpyBiotech
SpyBiotech Receives Grant from the Bill & Melinda Gates Foundation
Our 2022 HighlightsArticle links to innovation.ox.ac.uk
Oxford University retains No. 1 spot for spinouts
Oxford University retains No. 1 spot for spinoutsArticle links to www.ultromics.com
Ultromics
Ultromics granted FDA Breakthrough Device Designation

All News

Portfolio NewsGenomicsGenomics announces successful world-first pilot using improved genomic risk assessment in cardiovascular disease prevention in the NHSPortfolio NewsGenomicsGenomics announces genetic risk scoring partnership with Our Future Health to test new personalised disease prevention approachesPortfolio NewsGenomicsGenomics announces that Simon Dingemans has joined its board as the new chairPortfolio NewsGenomicsGenomics academic founder and CEO, Sir Peter Donnelly, awarded Royal Society Gabor medalPortfolio NewsGenomicsGenomics completes oversubscribed $30m funding round